Rx manufacturer vs compounder: Where to draw the lines
This article was originally published in Scrip
Executive Summary
"Do we need a bill or do we need an FDA that takes action?" Representative Tim Murphy (Republican-Pennsylvania) asked during a 16 July House hearing, spelling out, again, the issue his chamber has been grappling with for months – if not years – in the wake of more Americans being sickened and killed by tainted drugs compounded by pharmacies acting more like unregulated manufacturers.